The BIIB-Samsung FoB collaboration now has a formal name: Samsung Bioepis: http://www.financialpost.com/markets/news/Samsung+Biologics+Biogen+Idec+Announce+Formation+Biosimilars+Joint/6218672/story.html As one would expect, there is no pubic information regradng which FoB’s the companies plan to develop.